checkAd

     141  0 Kommentare Tiziana Responds to UK Call for Development of Innovative ‘Take Home’ Treatments for COVID-19 Disease - Seite 3

    For further enquiries:  
       
    United Kingdom:  
       
    Tiziana Life Sciences plc  
       
    Gabriele Cerrone, Chairman and founder +44 (0)20 7495 2379
       
    United States:  
    Investors:  
    Dave Gentry, CEO  
    RedChip Companies Inc. 407-491-4498
    dave@redchip.com   

    Seite 3 von 3




    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Verfasst von globenewswire
    Tiziana Responds to UK Call for Development of Innovative ‘Take Home’ Treatments for COVID-19 Disease - Seite 3 NEW YORK and LONDON, June 17, 2021 (GLOBE NEWSWIRE) - Tiziana Life Sciences plc (NASDAQ: TLSA, LSE: TILS), a biotechnology company focused on innovative therapeutics for oncology, neurology, inflammation and infectious diseases announces that it …